Wang, Anyi
Hirose, Takuo
Ohsaki, Yusuke
Takahashi, Chika
Sato, Emiko
Oba-Yabana, Ikuko
Kinugasa, Satoshi
Muroya, Yoshikazu
Ito, Sadayoshi
Mori, Takefumi
Funding for this research was provided by:
Japan Society for the Promotion of Science (23659438, 25860156, 26670424, 15K18694, 15H04834, 16H05312)
Article History
Received: 16 March 2018
Accepted: 29 October 2018
First Online: 13 November 2018
Compliance with ethical standards
:
: T.M. and S.I. are consultants for a clinical trial being conducted by Otsuka Pharmaceutical. T.M. has also received honoraria for lectures and research funding from Otsuka Pharmaceutical. The Division of Integrative Renal Replacement Therapy is financially supported by Terumo, JMS, Kyowa Hakko Kirin, and Otsuka Pharmaceutical.
: All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted (IRB approval number: 2015MdA-085 and 2016MdA-177).